|
Christian Bréchot
Vice President for Medical and Scientific Affairs,
INSTITUT MERIEUX
"BIOBANKING : a challenge for public / private partnerships"
|
|
|
Jan-Eric Litton
Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
"Connecting Biobanks"
|
| |
|
|
|
|
|
Michael Christman
President and CEO, Coriell Institute for Medical Research, Camden, NJ, United States
"Biobanking in the Era of Whole Genome Sequencing and Personalized Medicine"
|
|
|
JJ Nietfeld
University Medical Center Utrecht, Department of Pathology, Utrecht, NL
Jan-Eric Litton
Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
"The Bio-PIN: A tool that can solve biobanking problems"
|
| |
|
|
|
|
|
Jim Vaught
Office of Biorepositories & Biospecimen Research, NCI, Bethesda, Maryland USA
"Biobank Business Planning and Economic Impact"
|
|
|
Laurence Mabile & Anne Cambon-Thomsen
UMR U 1027, Inserm, Université de Toulouse - Université Paul Sabatier -Toulouse III, Toulouse, France
"The importance of tools to follow-up the research use of biobanks in the landscape of long term funding" |
| |
|
|
|
|
|
Philippe Van der Hofstadt
Chief Executive Officer, B&C Group, Mont-St-Guibert, Belgium
"From patient bedside to the long-term archive of biological specimens: challenges & opportunities"
|
|
 |
Hartmut Juhl
Chief Executive Officer, Indivumed GmbH and Inostics GmbH, Hamburg, Germany
"Stratification of cancer patients in clinical trials: challenges and opportunities"
|
| |
|
|
|
|
|
Jacqueline Mackenzie-Dodds
Natural History Museum, London
"Biobanking at the Natural History Museum London"
|
|
|
Heinz Ruedel
Fraunhofer IME, Schmallenberg, Germany
"The German Environmental Specimen Bank as a Tool for the Retrospective Monitoring of Chemicals of Concern"
|
| |
|
|
|
|
 |
Maura Ferrari
IZSLER, Brescia, Italy
"Development of a Veterinary Biobanking Infrastructure at IZSLER"
|
|
 |
Tomasz Stadejek
National Veterinary Research Institute, Pulawy, Poland
"Explore unexplored: origin of PRRSV revealed?"
|
| |
|
|
|
|
|
Filippo Franchini
A.I.S.EA Onlus, Verderio Superiore, Italy
"I.B.AHC - A Proposal for Networking European BioBanks on AHC"
|
|
|
Ann Cooreman
Tissue Solutions Ltd, Clydebank, Scotland, UK
"Working with Virtual Bio Banks: Pros and Cons"
|
| |
|
|
|
|
|
Michiel Verlinden
KU Leuven, Leuven, Belgium
"Access rules within biobank networks"
|
|
 |
Mª Angeles Muñoz Fernandez
HIV HGM Spanish BioBank, Madrid, Spain
HIV HGM Spanish BioBank contribution to research and treatment of diverse illnesses
|
| |
|
|
|
|
|
Anne-Lise Fabre
Imagene Company, Univ of Bordeaux, France
"Innovative Technology for Ribonucleic acid (RNA) Biobanking at Room Temperature"
|
|
 |
Johann van Niekerk
Brooks Automation Life Science Systems, Manchester, UK
"Quality Control in Biobanking: Applying vision technology to calculate sample volume in a tube"
|
| |
|
|
|
|
|
Sophie Visvikis-Siest
Unité de Recherche Génétique Cardiovasculaire, Nancy, France
"Influence of pre-analytical variables on VEFGA gene expression and circulating protein concentrations"
|
|
 |
Jeanne-Hélène di Donato
Consultant, 3C-R, France
"Biobanks for quality and networks for quantity: two cornerstones for human health research"
|
| |
|
|
|
|
| |
|
|
|
|
| |
 |
 |
|
|
|
|
